ArticleOncotarget2016

The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance.

Kevin S Quackenbush et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.